Rituxan (rituximab) - Roche
cyclophosphamide - Generic mfg.
Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody Vasculitis With Isolated Renal Presentation in an Older Female Patient: A Diagnostic and Therapeutic Challenge. (PubMed, J Med Cases) - Oct 15, 2026 - "Cyclophosphamide was successfully used as an alternative induction treatment. Following negative allergological evaluation and cautious re-exposure, rituximab was subsequently resumed for maintenance therapy and was well tolerated. Late-onset MPO-ANCA-associated vasculitis can have a favorable prognosis when diagnosed early and managed with appropriate immunosuppressive regimens." 
Journal • Acute Kidney Injury • ANCA Vasculitis • Fibrosis • Glomerulonephritis • Immunology • Lupus Nephritis • Nephrology • Renal Disease • Vasculitis • MPO
http://www.ncbi.nlm.nih.gov/pubmed/42872282
 
Abrar Ahmad Zulfiqar; Alexandre Sebaux
 
Oct 15, 2026
 
Prev Next